Neurology Peer Reviewers

Anthony A Amato, MD

Professor of Neurology

Harvard Medical School

Disclosure: Consultant/Advisory Boards: Novartis [Myositis]; Acceleron [Muscular dystrophy]; Akashi [Muscular dystrophy].

Carl W Bazil, MD, PhD

Caitlin Tynan Doyle Professor of Clinical Neurology

Director, Division of Epilepsy and Sleep

Columbia University College of Physicians and Surgeons

Disclosure: Nothing to disclose

Carolyn A Bernstein, MD, FAHS

Assistant Professor of Neurology

Harvard Medical School

Disclosure: Consultant/Advisory Boards: Amgen [Headache].

Jose Biller, MD, FACP, FAAN, FAHA

Section Editor — Stroke

Professor of Neurology and Neurological Surgery

Chairman Department of Neurology

Loyola University Chicago

Stritch School of Medicine

Disclosure: Nothing to disclose

Valérie Biousse, MD

Cyrus H. Stoner Professor of Ophthalmology

Professor of Ophthalmology and Neurology

Emory University

Disclosure: Nothing to disclose

Deborah Y Bradshaw, MD

Residency Program Director

Department of Neurology

Upstate Medical University

Disclosure: Grant/Research/Clinical Trial Support: Cytokinetics, Inc [ALS (Tirasemtiv)].

Charles R Cantor, MD

Professor of Clinical Neurology

University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose

Gregory D Cascino, MD

Professor of Neurology

Mayo Clinic, Rochester

Disclosure: Equity Ownership/Stock Options: Received stock through Mayo Foundation, Rochester, MN. (Mayo Medical Ventures) from NEVRO (Redwood City, CA) for SENZA Spinal cord stimulator: chronic intractable back pain (FDA approved).

Vanja Douglas, MD

Assistant Clinical Professor of Neurology

University of California San Francisco School of Medicine

Disclosure: Nothing to disclose

Eric Eggenberger, DO

Professor and Vice-Chairman, Neurology

Michigan State University

Disclosure: Grant/Research/Clinical Trial Support: Biogen [MS (natalizumab)]; Novartis [MS (fingolimod)]. Speaker's Bureau: Genzyme [MS (teriflunomide)]; Novartis [MS (dalfampridine)]; Acorda [MS (fingolimod)]. Consultant/Advisory Boards: Genzyme [MS (teriflunomide)]; Teva [MS (glatiramer)]. Equity Ownership/Stock Options: Lifeblood [MS].

Edward Feldmann, MD

Professor of Neurology

Tufts University School of Medicine

Disclosure: Nothing to disclose

Michael T Fitch, MD, PhD

Assistant Professor, Department of Emergency Medicine

Wake Forest University

Disclosure: Nothing to disclose

Charles C Flippen II, MD

Associate Professor

David Geffen School of Medicine at UCLA

Disclosure: Equity Ownership/Stock Options: Amgen [Headache: (Experimental drug)].

Joseph M Furman, MD, PhD

Professor

University of Pittsburgh

Disclosure: Nothing to disclose

Lawrence J Hirsch, MD

Professor of Neurology

Yale University School of Medicine

Chief

Division of Epilepsy and EEG

Co-Director

Yale Comprehensive Epilepsy Center

Disclosure: Grant/Research/Clinical Trial Support: Upsher-Smith [Epilepsy (Long-acting topiramate, nasal midazolam)]; Eisai [Epilepsy (Perampanel, zonisamide, rufinamide)]. Consultant/Advisory Boards: Monteris [Epilepsy (laser surgery)]; Ceribell [Epilepsy (EEG device)]; Eisai [Epilepsy (perampanel, zonisamide, rufinamide)]; Neuropace [Epilepsy (responsive neurostimulator)]; Sun Pharma [Epilepsy (long acting formulations)]; Engage Therapeutics [Epilepsy (acute benzodiazepine)]. Other Financial Interest: Wiley [Atlas of EEG (Author royalties)]; Medlink Neurology [Epilepsy sections (Author royalties)].

Jonathan Howard, MD

Assistant Professor of Neurology and Psychiatry

NYU Langone School of Medicine

Disclosure: Nothing to disclose

Lara Jehi, MD

Associate Professor

Cleveland Clinic Lerner College of Medicine

Disclosure: Nothing to disclose

Thomas Kaley, MD

Memorial Sloan Kettering Cancer Center

Disclosure: Nothing to disclose

Steven Karceski, MD

Assistant Professor of Neurology

Weill Cornell Medical College

Disclosure: Speaker's Bureau: Cyberonics [Epilepsy (Vagus nerve stimulator)]; Neuropace [Epilepsy (Vagus nerve stimulator)].

Daniel I Kaufer, MD

Chief, Cognitive & Behavioral Neurology

Director, UNC Memory Disorders Program

University of North Carolina at Chapel Hill

Disclosure: Grant/Research/Clinical Trial Support: Abbvie [PSP (8E12 ant-tau antibody)]; TauRx [Memory disorders (LTMT)]; Navidea Biopharmaceuticals [Memory disorders (NAV4694)]; Janssen Research and Development [Memory disorders (Memory test validation)]; Axovant [Memory disorders (RVT-101, nelotanserin)]; Neurim pharmaceuticals [Memory disorders (Piromelatine)]. Consultant/Advisory boards: Takeda [Memory disorders (Pigolitazone)]; Janssen Research and Development [Memory disorders (Memory test validation)]; Axovant [Memory disorders (RVT-101, nelotanserin)].

Christian M Korff, MD

Head, Pediatric Neurology

Geneva University Hospitals

Disclosure: Nothing to disclose

Geoffrey Littlejohn, MD

Associate Professor of Medicine

Monash University, Australia

Disclosure: Speaker's Bureau: Pfizer [Neuropathic pain/fibromyalgia (Pregabalin)].

Andrew L Lux, MSc, PhD, FRCPCH

Consultant in Paediatric Neurology

Bristol Royal Hospital for Children

Disclosure: Nothing to disclose

Kenneth J Mack, MD, PhD

Professor of Neurology and Pediatrics

Mayo Medical School

Disclosure: Consultant/Advisory Boards: Amgen [Headache (Products in development)].

Anil Mendiratta, MD

Associate Professor of Neurology

Columbia University College of Physicians and Surgeons

Disclosure: Nothing to disclose

Stephanie Nahas, MD, MDEd

Assistant Professor of Neurology

Thomas Jefferson University

Disclosure: Consultant/Advisory Boards: Supernus [Headache (Trokendi XR)]; Lilly [Headache (drug not yet released, galcanezumab)].

Alison M Pack, MD

Associate Professor of Clinical Neurology

Columbia University College of Physicians and Surgeons

Disclosure: Nothing to disclose

Juliann M Paolicchi, MA, MD

Professor of Clinical Pediatrics

Rutgers Medical School

Disclosure: Grant/Research/Clinical Trial Support: Zogenix [Epilepsy (fenflramine)]. Speaker’s Bureau: Lundbeck Pharm [Epilepsy (Vigabatrin, Clobazam)]; Cyberonics [Epilepsy (VNS)].

Marc C Patterson, MD, FRACP

Section Editor — Pediatric Neurology

Professor of Neurology, Pediatrics, and Medical Genetics

Chair, Division of Child and Adolescent Neurology

Mayo Clinic College of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Vtesse [Niemann-Pick C (Cyclodextrin)]. Consultant/Advisory Boards: Actelion [Niemann-Pick C (Miglustat)]; Agios [CGD]; Alexion [General lysosomal diseases, lysosomal acid lipase deficiency (Sebelipase alfa)]; Amicus [Fabry, Gaucher, Pompe (Migalastat)]; Novartis [MS]; Shire [MLD]. Other Financial Interest: Sage [Honorarium as Editor-in-Chief of Journal of Child Neurology and Child Neurology Open].

Stephen Reich, MD

The Frederick Henry Prince Distinguished Professor in Neurology

The University of Maryland School of Medicine

Disclosure: Nothing to disclose

Michael Ronthal, MD

Professor of Neurology

Harvard Medical School

Disclosure: Nothing to disclose

Sean Ruland, DO

Associate Professor

Loyola University Chicago-Stritch School of Medicine

Disclosure: Nothing to disclose

Steven C Schachter, MD

Professor of Neurology

Harvard Medical School

Disclosure: Grant/Research/Clinical Trial Support: LivaNova, PLC. [Epilepsy (Vagus nerve stimulator)].

David Schiff, MD

Professor of Neurology, Neurological Surgery, and Medicine

University of Virginia School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Cavion, Tocagen, Vascular Biogenics, Stemline [Glioblastoma]. Consultant/Advisory Boards: Genentech [Glioblastoma, oligodendroglioma (bevacizumab)]. Other Financial Interest: Vascular Biogenics (VB-111), Orbus, Monteris.

Duygu Selcen, MD

Associate Professor of Neurology

Mayo Clinic Rochester

Disclosure: Nothing to disclose

Jeremy M Shefner, MD, PhD

Section Editor — Neuromuscular Disease

Professor and Chair of Neurology, Barrow Neurological Institute

Professor of Neurology, University of Arizona, Phoenix

Clinical Professor of Neurology, Creighton University

Disclosure: Grant/Research Support: Biogen Idec; Cytokinetics; Neuraltus [ALS]; Avanir [ALS (Nuedexta)]. Consultant/Advisory Boards: Biogen Idec; Cytokinetics; Ionis; Neuraltus; Mitsubishi Tanabe [ALS]; Edaravone [ALS (MT Pharma)].

Joseph I Sirven, MD

Professor and Chair of Neurology

Mayo Clinic College of Medicine

Disclosure: Nothing to disclose

David E Thaler, MD, PhD, FAHA

Interim Chairman, Department of Neurology

Tufts Medical Center, Tufts University School of Medicine

Disclosure: Consultant/Advisory Boards: St Jude Medical [PFO (Amplatzer PFO Occluder)].

Joshua Z Willey, MD, MS

Assistant Professor of Neurology

Columbia University

Disclosure: Grant/Research/Clinical Trial Support: AstraZeneca [Transient ischemic attack (Ticagrelor)]; Genentech [Minor stroke (Alteplase)]; NIH [Stroke epidemiology]; NIH [Stroke (Clopidogrel)]; Reliant Heart [Clinical Endpoint Committee (Left ventricular assist device)]; Claret Medical [Clinical Endpoint Committee (Embolic protection device in percutaneous aortic valve replacement)]. Consultant/Advisory Boards: HeartWare [Stroke (Ventricular assist device)].